14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

IMGN Predictions History

4 years ago
joe1234 predicted that IMGN for 2019-05-16 is going $2.23 (13.20%)

4 years ago
Alex.TinyVillianaire.Goh.110165 predicted that IMGN for 2019-05-16 is going $3.36 (57.01%)

Rank:

4 years ago
joe1234 predicted that IMGN for 2019-05-10 is going $3.30 (1.54%)

4 years ago
GoldenNugget predicted that IMGN for 2019-05-07 is going $2.86 (-13.29%)

5 years ago
NameNotImportant predicted that IMGN for 2019-04-30 is going $2.41 (0.84%)

5 years ago
JS predicted that IMGN for 2019-03-06 is going $2.89 (7.43%)

5 years ago
PumpTheseNumbers predicted that IMGN for 2019-03-06 is going $2.94 (9.29%)

5 years ago
Gp predicted that IMGN for 2019-03-04 is going $1.24 (-50.60%)

5 years ago
JS predicted that IMGN for 2019-03-04 is going $2.65 (5.58%)

5 years ago
PumpTheseNumbers predicted that IMGN for 2019-03-04 is going $3.12 (24.30%)

Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT